advertisement

WGA Rescources

Park YH 11

Showing records 1 to 11 | Display all abstracts from Park YH

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim SN
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Moon JY
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Ko SA
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Kim HJ
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park CG
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park YH; Park TK
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Lee SH
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park EC
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Huh BK; Park YH
Molecular pharmaceutics 2018; 15: 3143-3152
78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Kim CY; Lee SH
Scientific reports 2018; 8: 11161
78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim YK; Ha A; Park KH; Choy YB
Molecular pharmaceutics 2018; 15: 3143-3152

Issue 19-4

Change Issue


advertisement

Oculus